Stay updated on Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T14:51:47.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-12T14:55:37.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 entry was added to the history, and the previous Revision: v3.6.6 entry was removed, indicating a minor version update in the page's history log.
    Difference
    0.0%
    Check dated 2026-09-21T22:22:09.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A new history entry on 2026-09-01 adds an update to the Study Status (version 78), and an entry from 2026-08-13 was removed. This documents a fresh status update and a historical cleanup in the trial's record history.
    Difference
    0.2%
    Check dated 2026-09-07T20:56:40.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry, v3.6.6, replacing the previous v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-31T16:46:30.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The study history now indicates that results have been posted and additional core data sections (adverse events, baseline characteristics, participant flow, outcome measures, and arms/interventions) are now available in the record, reflecting a more complete posting of trial data.
    Difference
    0.6%
    Check dated 2026-08-17T12:18:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.